V. Vaidyula

发表

Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease

J. Gaughan, A. Comerota, A. Rao, 2006, Thrombosis and Haemostasis.

Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand.

C. Homko, M. Mozzoli, G. Boden, 2006, Diabetes.

Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects

G. Boden, A. Rao, V. Vaidyula, 2006, Platelets.

Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: Impact of hyperglycemia

J. Gaughan, N. Gentile, A. Rao, 2007, Thrombosis and Haemostasis.

Role of Gαq and phospholipase C‐β2 in human platelets activation by thrombin receptors PAR1 and PAR4: studies in human platelets deficient in Gαq and phospholipase C‐β2

A. Rao, V. Vaidyula, 2003 .

Lineage-specific defect in gene expression in human platelet phospholipase C-beta2 deficiency.

S. Kunapuli, A. Rao, G. Mao, 2002, Blood.

Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.

C. Homko, G. Boden, P. Cheung, 2007, The Journal of clinical endocrinology and metabolism.

Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease.

G. Criner, Carla L Grabianowski, A. Rao, 2009, Thrombosis research.

Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.

C. Homko, M. Mozzoli, G. Boden, 2007, American journal of physiology. Endocrinology and metabolism.

Role of Galphaq and phospholipase C-beta2 in human platelets activation by thrombin receptors PAR1 and PAR4: studies in human platelets deficient in Galphaq and phospholipase C-beta2.

A. Rao, V. Vaidyula, 2003, British journal of haematology.